Overview

Intraoperative Fluid Management in Laparoscopic Bariatric Surgery

Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
0
Participant gender:
All
Summary
The objective of this study is to evaluate the effects of 'high' versus 'low' volume intraoperative fluid administration (Ringer Lactate, RL) on intra- and postoperative parameters, in obese patients undergoing laparoscopic bariatric surgery (i.e., gastric bypass), in order to establish evidence-based data for perioperative fluid management in this patient population. Based on their experience as well as several reports in the literature, the investigators hypothesized that a restrictive approach to intraoperative hydration will reduce the incidence of postoperative complications and the recovery time of gastrointestinal (GI) function, and shorten hospital stay.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Tel-Aviv Sourasky Medical Center
Treatments:
Pharmaceutical Solutions
Criteria
Inclusion Criteria:

- Adult patients ( >18 years) with an American Society of Anesthesiology physical status
of I-III who were presenting for laparoscopic bariatric surgery, were prospectively
studied.

- Patients were considered eligible if they had a BMI > 40, or > 35 and at least one
comorbid condition and were scheduled to undergo one of the following laparoscopic
operations:

- Roux-Y Gastric Bypass (LRYGB)

- Biliopancreatic Diversion with Duodenal Switch (LDS), or

- Sleeve Gastrectomy (LSG).

Exclusion Criteria:

- Patients aged younger than 18 years.

- Patients with renal dysfunction (creatinine > 50% upper limit of normal value).

- Congestive heart failure.